零差评SEO网络：谷歌竞价推广国家选择与创新药械全球化布局

零差评SEO网络：谷歌竞价推广国家选择与创新药械全球化布局

Zero-Complaint SEO Network: Google Ads Country Selection and Innovative Pharma/Device Globalization Strategies

随着创新药械"出海"热潮兴起，全球化布局正形成新模式。 复星国际联席首席执行官陈启宇表示："产品属性差异决定了出海策略的不同。仿制药需考虑成本竞争，而创新药需要构建完整的本地化营销体系。"

As the wave of innovative pharmaceuticals/medical devices "going global" rises, new globalization models are emerging. Chen Qiyu, Co-CEO of Fosun International, stated: "Different product attributes determine different globalization strategies. Generic drugs need to consider cost competition, while innovative drugs require building complete localized marketing systems."

全球化布局现状

Current Status of Globalization

2024年前三季度数据显示：

• 药品对外授权交易73笔，总金额336亿美元
• 医疗器械出口额353.39亿美元，同比增长4.63%

Data from the first three quarters of 2024 shows:

• 73 pharma licensing-out deals totaling $33.6 billion
• Medical device exports reached $35.339 billion, up 4.63% YoY

药品与医疗器械出海差异

Differences Between Pharma and Device Globalization

中金资本刘森林指出三大区别：

1. 风险程度：医疗器械风险更可控
2. 创新成本：药品更强调创新性
3. 市场规模：药品市场规模通常更大

Liu Senlin from CICC Capital highlights three key differences:

1. Risk level: Medical devices have more controllable risks
2. Innovation cost: Pharma emphasizes innovation more
3. Market size: Pharma typically has larger markets

新兴出海模式

Emerging Globalization Models

药品领域：

• "借船出海"模式：与海外合作伙伴共享收益
• NewCo模式：通过海外资本设立新公司

Pharma sector:

• "Borrowing ships" model: Sharing benefits with overseas partners
• NewCo model: Establishing new companies through overseas capital

医疗器械领域：

• 从代工转向自主品牌注册
• 高端化、多元化、常态化趋势

Medical device sector:

• Transitioning from OEM to independent brand registration
• Trend toward high-end, diversified and normalized exports

SEO与谷歌竞价推广策略

SEO and Google Ads Strategies

对于选择谷歌竞价推广国家：

• 优先考虑目标市场法规环境
• 分析当地搜索习惯和关键词
• 建立本地化营销团队

For selecting Google Ads countries:

• Prioritize target market regulatory environments
• Analyze local search habits and keywords
• Establish localized marketing teams

成功案例：海尔生物在90多个"一带一路"国家落地疫苗解决方案，通过7次技术迭代成为全产业链供应商。

Success case: Haier Biotech deployed vaccine solutions in over 90 Belt and Road countries, becoming a full-industry-chain supplier through 7 technology iterations.

未来挑战与建议

Future Challenges and Recommendations

专家建议：

• 药品：加强全球化临床能力建设
• 器械：研发阶段即考虑国际法规要求
• 共同：重视国际认证(ISO/CE/FDA)

Expert recommendations:

• Pharma: Strengthen global clinical capabilities
• Devices: Consider international regulations during R&D
• Common: Value international certifications (ISO/CE/FDA)